Two organizations are fighting a legal battle over what has been called a “cancer cure” developed at Penn, Newsworks reported.
St. Jude’s Research Hospital in Memphis, Tenn. sued Penn in 2012, saying that Penn broke the organizations’ research agreement. Penn countersued St. Jude’s, challenging its patent for the cancer treatment that Penn is using.
The two parties are set to meet with a federal judge later this month.
Research agreements are subject to legal battles every step of the way: Boston Children’s Hospital is currently engaged in a lawsuit with North Jersey-based pharmaceutical company Celgene over royalties it says its owed on cancer drugs, the Wall Street Journal reported.
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
3 ways to support our work:- Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
- Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
- Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
